BofA Securities Upgrades Galera Therapeutics (GRTX) to Neutral
Tweet
Share
E-mailGet Alerts GRTX Hot Sheet
Price: $0.15 --0%
Rating Summary:
3 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
3 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
BofA Securities analyst Tazeen Ahmad upgraded Galera Therapeutics (NASDAQ: GRTX) from Underperform to Neutral with a price target of $4.00 (from $2.00).
For an analyst ratings summary and ratings history on Galera Therapeutics click here. For more ratings news on Galera Therapeutics click here.
Shares of Galera Therapeutics closed at $1.38 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- HSBC Upgrades YPF S.A. (YPF) to Buy
- Rothschild Redburn Upgrades Apple (AAPL) to Buy
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
